期刊文献+

黄酮“落新妇苷”对胰脂肪酶抑制作用研究 被引量:5

The inhibiting effect of flavonoid “astilbin” on pancreatic lipase
下载PDF
导出
摘要 通过研究落新妇苷对胰脂肪酶的抑制活性,进一步探索其调节脂肪代谢的可能原因。结果表明,落新妇苷对胰脂肪酶有一定的抑制作用,半抑制率浓度为105μmol/L,最大抑制率为56.3%;且抑制效果随二者作用时间延长而增强。酶动力学特征研究表明,落新妇苷是胰脂肪酶非竞争性抑制剂,不改变其与底物的亲和程度,但使最大反应速度减小。荧光光谱滴定法表明落新妇苷会使胰脂肪酶内源荧光淬灭,并使其最大发射波长红移,二者结合常数lg Ka为5.50,结合位点数n为1.17。 In this paper,we studied the inhibitory activity of astilbin on pancreatic lipase. The results showed that astilbin had inhibitory effect on pancreatic lipase with IC50 of 105 μmol/L and maximum inhibition rate of 56. 3%. The inhibitory effect increased with the interaction time between astilbin and pancreatic lipase. Enzyme kinetics study showed that astilbin was a noncompetitive inhibitor of pancreatic lipase,which did not change its affinity with the substrate,but decreased its maximum reaction rate. The fluorescence spectra showed that astilbin could quench the endogenous fluorescence of pancreatic lipase,and made its maximum emission wavelength red shift. Their binding constant(lgK_a) was 5. 50 and the binding-site number was 1. 17.
作者 郑丹 张清峰
出处 《食品与发酵工业》 CAS CSCD 北大核心 2018年第2期172-175,181,共5页 Food and Fermentation Industries
基金 国家自然科学基金项目(31760461) 江西省教育厅基金项目(GJJ160416) 江西省天然产物与功能食品重点实验室开放基金项目(2015003)
关键词 落新妇苷 胰脂肪酶 抑制作用 astilbin pancreatic lipase inhibiting effect
  • 相关文献

参考文献4

二级参考文献43

  • 1吴丽明,张敏.土茯苓中落新妇甙的利尿和镇痛作用[J].中药材,1995,18(12):627-630. 被引量:82
  • 2李国莉,赵伟明,杨建军,刘贺荣,任彬彬,赵燚,李蕾,康志东.大豆异黄酮降血脂作用的研究[J].食品科学,2006,27(10):528-531. 被引量:30
  • 3Haslam D W, James W P. Obesity [J]. Lancet, 2005, 366 (9492): 1197-1209. 被引量:1
  • 4Kopelman P G. Obesity as a medical problem [J]. Nature, 2000, 404 (6778): 635-643. 被引量:1
  • 5Birari R B, Bhutani K K. Pancreatic lipase inhibitors from natural sources: unexplored potential [J]. Drug Discov Today, 2007, 12 (19-20): 879-889. 被引量:1
  • 6Guerciolini R. Mode of action of orlistat [J]. Int J Obes Relat Metab Disord, 1997, 21(3): 12-23. 被引量:1
  • 7Finer N, James W P, Kopelman P G, et al. One-year treatment of obe- sity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor[J]. Int J Obes Relat Metab Disord, 2000, 24(3): 306-313. 被引量:1
  • 8McNeely W, Benfield P. Orlistat[J]. Drugs, 1998, 56(2): 241-250. 被引量:1
  • 9Jang D S, Lee G Y, Kim J, et al. A new pancreatic lipase inhibitor iso- lated from the roots of Actinidia arguta[J]. Arch Pharm Res, 2008, 31 (5): 666-670. 被引量:1
  • 10Moreno D A, Ilic N, Poulev A, et al. Inhibitory effects of grape seed extract on lipases[J]. Nutrition, 2003, 19(10): 876-879. 被引量:1

共引文献34

同被引文献57

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部